Cancer cell motility-on the road from c-erbB-2 receptor steered signaling to actin reorganization

Experimental Cell Research

Volumn 272, Issue 2, 2002, Pages 93-108

  Feldner, Julia C ^a   Brandt, Burkhard H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; CALCIUM; COFILIN; FOCAL ADHESION KINASE; GELSOLIN; GUANOSINE TRIPHOSPHATASE; INTEGRIN; ISOENZYME; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PROFILIN; PROTEIN TYROSINE KINASE; SELECTIN; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN FILAMENT; CALCIUM SIGNALING; CANCER CELL; CELL MIGRATION; CELL MOTILITY; CYTOSKELETON; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036056156     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5385     Document Type: Review

References (93)

1. Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions
2. Localization of matrix metalloproteinases MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
3. Isolation of blood-borne epithelial derived erb-2 oncoprotein positive clustered cells from peripheral blood of breast cancer patients
4. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
5. Epidermal-growth factor receptors in human bladder cancer: Comparison of invasive and superficial tumours
6. erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties
7. erbB-2/EGF-R as dominant heterodimerization partners determine the motogenic phenotype in human breast cancer cells
8. Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model
9. Transformation mediated by the human Her-2 gene independent of epidermal growth factor receptor
10. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility
11. A role for phospholipase C-γ-mediated signaling in tumor cell invasion
12. Epidermal-growth factor receptor status as a predictor of early recurrence of and death from breast cancer
13. Human breast cancer: Correlation of relapse and survival with amplification of HER-2/neu oncogene
14. Actin: Protein structure and filament dynamics
15. Nucleotide hydrolysis in cytoskeletal assembly
16. Thymosine β4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes
17. Focusing on unpolymerized actin
18. 2 and inhibits its hydrolysis by phospholipase C
19. FAK integrates growth-factor and integrin signals to promote cell migration
20. Towards a new concept of cell motility: Cytoskeletal dynamics in amoeboid movement and cell division
21. Microfilament-based motility in non-muscle cells
22. Actin crosslinking proteins at the leading edge
23. Localization and dynamics of nonfilamentous actin in cultured cells
24. Life at the leading edge: The formation of cell protrusions
25. Comparison of actin and cell surface dynamics in motile fibroblasts
26. Hemostatic inflammatory and fibroblast responses are blunted in mice lacking gelsolin
27. Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly
28. Dynamics of capping protein and actin assembly in vitro: Uncapping barbed ends by phosphoinositides
29. Gelsolin is a downstream effector of Rac for fibroblast motility
30. Rocket-based motility: A universal mechanism?
31. Scar1 and the related Wiskott Aldrich syndrome protein WASp regulate the actin cytoskeleton through the Arp2/3 complex
32. Signaling to actin dynamics
33. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex
34. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signaling to actin cytoskeletal dynamics
35. Regulating actin-filament dynamics in vivo
36. Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion
37. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipodia extension
38. The EGF receptor is an actin binding protein
39. The interaction of Arp 2/3 complex with actin: Nucleation, high affinity pointed end capping, and formation of branching networks of filaments
40. Relationship between Arp2/3 complex and the barbed ends of actin filament at the leading edge of carcinoma cells after epidermal growth factor stimulation
41. The Arp2/3 complex branches filament barbed ends: Functional antagonism with capping proteins
42. Progress in protrusion: The tell-tale scar
43. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeleton rearrangement in a PIP2-dependent manner downstream of tyrosine kinase
44. Specific requirement for the p85-p110α phosphoinositol 3-kinase during epidermal growth factor stimulated actin nucleation in breast cancer cells
45. Cell spreading and lamellipodia extension rate is regulated by membrane tension
46. Gelsolin and functionally similar actin binding proteins are regulated by LPA
47. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositode synthesis in permeabilized human platelets
48. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products
49. Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production
50. Epidermal growth factor-activated calcium and potassium channels
51. Autophosphorylation sites on the epidermal growth factor receptor
52. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in human salivary gland adenocarcinomas
53. Isolation and characterization of ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
54. Ligand-specific activation of Her4/p180erbB4, a fourth member of the epidermal growth factor receptor family
55. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
56. Employment of epidermal growth factor receptor in growth factor-independent signaling pathways
57. Basic science of Her-2/neu: A review
58. The ErbB-2 Her2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
59. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
60. Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3
61. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways
62. Signal transduction by receptor tyrosine kinase activity
63. Characterization of a breast cancer cell differentiation factor that specifically activates the Her4/ p180erbB4 receptor
64. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
65. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases
66. Multiple positive negative regulators of signaling by the EGF-receptor
67. Expression of antisense epidermal growth factor receptor RNA down-modulates the malignant behavior of human colon cancer cells
68. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells
69. Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement
70. Differential endocytic routing of homo- and heterodimeric ErbB tyrosine kinases counters signaling superiority to receptor heterodimers
71. Phospholipase C-y1: Regulation of enzyme function and role in growth factor-development signal transduction
72. Essential role of tyrosine kinase substrate phospholipase C-γ1 in mammalian growth and development
73. Expression of phospholipase C-gamma 1 and its transcriptional regulators in breast cancer tissues
74. Cdc42 and rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
75. The transcription factor AP-1 is required for EGF-induced activation of Rho-like GTPases, cytoskeletal rearrangements, motility and in vitro invasion of A431 cells
76. Rho effectors and reorganization of actin cytoskeleton
77. Phosphoinositide kinases
78. Novel functional PI3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines
79. D-Myo-inositol 1,4,5,6-terakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways
80. Pleckstrin homology domains and phospholipid-induced cytoskeletal reorganization
81. The phospholipase Cγ (PLCγ) plays a key role in the migration of Her-2/Neu positive breast cancer cells
82. The differences in the epidermal growth factor induced locomotory phenotypes of HER2/Neu (c-erbB-2) positive and negative breast cancer cells are based on varying basal calcium signaling levels
83. Distinct migratory phenotypes in HER2/ neu positive and negative breast adenocarcinoma cells are caused by different PKC-α expression levels
84. A new erythrocyte membrane-associated protein with calmodulin binding activity. Identification and purification
85. The basal apparatus. Mass isolation from the molluscan ciliated gill epithelium and a preliminary characterization of striated rootlets
86. Cofilin, a protein in porcine brain that binds to actin filaments and inhibits their interaction with myosin and tropomyosin
87. Filamin, a new high-molecular-weight protein found in smooth muscle and non-muscle cells
88. Fimbrin, a new microfilament-associated protein present in microvilli and other cell surface structures
89. 2+-activated regulatory protein of macrophages
90. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to Ras signaling
91. Paxilin: A new vinculin-binding protein present in focal adhesions
92. Analysis, purification and properties of a 50,000-dalton membrane-associated phosphoprotein from human platelets
93. Vinculin, an intracellular protein localized at specialized sites where microfilament bundles terminate at cell membranes